PLAINSBORO, N.J., April 14, 2025 /PRNewswire/ -- Novo Nordisk has become aware of several hundred units of Ozempic ® (semaglutide) injection 1 mg distributed outside the Novo Nordisk authorized ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

A new study found that Ozempic's main ingredient may treat people with type 1 diabetes, control blood sugar, and lose weight.

Both drugs come as an injection. Ozempic is not available as a ... Efficacy and safety of once-weekly semaglutide 1.0 mg vs. once-daily liraglutide 1.2 mg as add-on to 1–3 oral ...

Would you get a one-time genetic modification such that you'd never have to take a GLP-1 drug for weight loss ever again?

The U.S. Food and Drug Administration (FDA) and Novo Nordisk are warning people not to use counterfeit semaglutide 1.0 mg (Ozempic injection) found in the US drug supply chain. Novo Nordisk ...

Ozempic’s active ingredient is semaglutide, which belongs to a class of medications called incretin mimetics, and was approved as a treatment for type 2 diabetes via a 1-milligram injection in 2017.